Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: A 2-year follow-up report of a national, prospective prostatic cancer study

British Journal of Urology

Volumn 82, Issue 1, 1998, Pages 63-68

  Mikkola, A K K ^a   Ruutu, M L ^a   Aro, J L V ^a   Rannikko, S A S ^b   Salo, J O ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Maria Hospital   (Finland)

Author keywords

Cardiovascular complication; Parenteral oestrogen therapy; Progression; Prostatic cancer

Indexed keywords

ESTROGEN; POLYESTRADIOL PHOSPHATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FOLLOW UP; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; ESTRADIOL; ESTRADIOL CONGENERS; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; ORCHIECTOMY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0031847875     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1998.00688.x     Document Type: Article

References (29)

1. Huggins C, Hodges CV, Studies on prostatic cancer. Effect of castration, of estrogen and of androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-7
2. Torti F, Hormonal therapy for prostate cancer. N Engl ] Med 1984; 311: 1313-4
3. Glashan RW, Robinson MRG, Cardiovascular complications in the treatment of prostatic carcinoma. Br J Urol 1981; 53: 624-7
4. Haapiainen R, Rannikko S, Alfthan 0. Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective cancer study. Er] Urol 1986: 58: 528-33
5. Aro JLV, Haapiainen RK, Rannikko SAS, Alfthan OS and the Finnprostate Group. High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Br ] Urol 1989; 63: 512-4
6. Haapiainen R, Rannikko S, Alfthan 0 and the Finnprostate Group. Comparison of primary orchiectomy and polyoestradiol phosphate in the treatment of advanced prostatic cancer. Br ] Urol 1990: 66: 94-7
7. Stege R, Gunnarsson P, Johansson C-J, Olsson P, Pousette A, Carlström K, Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients. Prostate 1996; 28: 307-10
8. Stege R, Carlström K, Collste L et al. Single-drug parenteral estrogen treatment in prostatic cancer: A study of two maintenance-dose regimens. Prostate 1989: 14: 183-8
9. Norlen B], Fritjofsson A, Grönquist L et al. Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer. Eur Urol 1987; 13: 193-7
10. Stege R, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A, Single-drug polyestradiol phosphate therapy in prostatic cancer. Am }Clin Oncol 1988; 11: S101-3
11. International Histological Classification of Tumours. Histological Typing of Prostate Tumours, WHO, Geneva. 1980; 22: 17-23
12. UICC, TNM classification of malignant tumours. 3rd edn. Geneva, 1978, Enlarged and revised 1982
13. Alfthan O, Holsti LR, Prevention of gynecomastia by local roentgen irradiation in estrogen-treated prostatic carcinoma. Scand] Urol Nephrol 1969: 3: 183-7
14. Schroeder FH, Treatment response criteria for prostatic cancer. Prostate 1984: 5: 181-91
15. 5 Hakama M, Hakulinen T, Estimating the expectation of life in cancer survival studies with incomplete follow-up information. / Chron Dis 1977: 30: 585-97
16. Jönsson G, Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol. Scand ] lira! Nephrol 1971: 5: 97-102
17. Haapiainen R, Rannikko S, Ruutu M et al. Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer. Er] Urol 1991: 67: 184-7
18. Aro J, Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population. Prostate 1991; 18: 131-7
19. Stege R, Frölander N, Carlström K et al. Steroid sensitive proteins, growth hormone and somatomedin C in prostatic cancer. Effects of parenteral and oral estrogen therapy. Prostate 1987: 10: 333-8
20. Rossner S, Hedlund P-O, Jogestrand T, Sawe U, Treatment of prostatic cancer: Effects on serum lipoproteins and the cardiovascular system. / Urol 1985: 133: 53-7
21. Aro J, Haapiainen R, Sane T, Rannikko S, Pelkonen R, Alfthan 0. Effects of orchiectomy and polyestradiol phosphate therapy on serum lipoprotein lipids and glucose tolerance in prostatic cancer patients. Eur Urol 1990: 17: 229-35
22. Berglund L, Carlström K, Stege R et al. Hormonal regulation of serum lipoprotein (a) levels: Effects of parenteral administration of estrogen or testosterone in males. / Clin Endocrinol Metab 1996; 81: 2633-7
23. Expert Panel on Detection. Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). ] Am Med Assoc 1993; 269: 3015-23
24. Cremer P, Nagel D, Mann H et al. Ten-year follow-up results from the Goettingen Risk. Incidence and Prevalence Study (GRIPS). I, Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis 1997: 129: 221-30
25. Henriksson P, Blombac M, Bratt G, Edhag 0. Eriksson A, Vesterqvist 0. Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer. Med Oncol Tumor Pharmacother 1989; 6: 219-25
26. Aro J, Haapiainen R, Rasi V, Rannikko S, Alfthan O, The effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patients. Eur Urol 1990; 17: 161-5
27. Henriksson P, Blombäck M, Eriksson A, Stege R, Carlström K, Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma. Br Med }1990; 65: 282-5
28. Iversen P, Combined androgen blockade in the treatment of advanced prostate cancer -an overview. Scand J Urol Nephrol 1997; 31: 249-54
29. Finnish Cancer Registry -Institute for Statistical and Epidemiological Cancer Research. Cancer incidence in Finland 1994. Cancer Statistics of the National Research and Development Center for Welfare and Health. Cancer Society of Finland, Publication no. 57. Helsinki 1996 30 Flanders WD, Review: prostate cancer epidemiology. Prostate 1984: 5: 621-9